☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ards
Recent Insights into Advances of COVID-19 Treatment
May 27, 2021
Novartis Signs a License Agreement with Mesoblast to Develop and Commercialize Remestemcel-L for ARDS
November 20, 2020
Athersys Reports Results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS)
January 24, 2019
Load more...
Back to Home
